Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

• Hiroyuki Futatsugi,
• Masato Iwabu,
• Miki Okada-Iwabu,
• Miki Okada-Iwabu,
• Koh Okamoto,
• Yosuke Amano,
• Yutaka Morizaki,
• Takashi Kadowaki,
• Takashi Kadowaki,
• Takashi Kadowaki,
• Toshimasa Yamauchi

Affiliations

Hiroyuki Futatsugi

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Masato Iwabu

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Miki Okada-Iwabu

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Miki Okada-Iwabu

Laboratory for Advanced Research on Pathophysiology of Metabolic Diseases, The University of Tokyo, Tokyo, Japan

Koh Okamoto

Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan

Yosuke Amano

Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan

Yutaka Morizaki

Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan

Takashi Kadowaki

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Takashi Kadowaki

Department of Prevention of Diabetes and Life-Style Related Diseases, The University of Tokyo, Tokyo, Japan

Takashi Kadowaki

Toranomon Hospital, Tokyo, Japan

Toshimasa Yamauchi

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan